LM103 for advanced solid tumors using donated immune cells
Treatments studied
Part of Cancer, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This Phase 1 study tests LM103 to treat advanced cancers that are not responding to standard treatment. It also looks at whether enough tumor tissue can be collected for immune cell testing, and focuses on safety at first.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage III or IV melanoma, non-small cell lung cancer, cervical cancer, or another solid tumor confirmed by biopsy, and standard options aren’t working or there is no standard option
- Your doctors can take a tumor sample for testing (biopsy or surgery) and there is enough tissue available (more than 1.5 cm³)
- Your blood counts are in a safer range (including enough white blood cells, platelets, and hemoglobin)
- Your heart and organ function are strong enough (heart pumping—LVEF—at least 50%, plus liver and kidney blood tests not too high)
- Your physical functioning is fairly good (ECOG 0–1) and you’re expected to live more than 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes). The cells are taken from a tumor sample, multiplied in a lab, and given back to you to help fight the cancer. It's for people with melanoma that has not responded to standard immunotherapy.
This trial tests a personalized treatment using your own immune cells (called TILs) to fight advanced non-small cell lung cancer that has progressed after standard therapy. You would have surgery to collect a tumor sample, then receive your expanded immune cells back as an infusion.
This trial tests an investigational treatment called LM303 for people with advanced solid tumors like melanoma, lung cancer, or cervical cancer. It uses your own immune cells (called TILs) to fight the cancer, so you need a tumor large enough for cells to be collected.
This trial tests a new drug called LM103 for people with advanced melanoma who have already tried several standard treatments, including immunotherapy. The goal is to see if LM103 can help shrink tumors when other treatments have stopped working.
This trial tests a type of immune cell treatment called TIL (tumor-infiltrating lymphocytes) in people with advanced solid cancers. It may help your immune system better recognize and attack tumors, especially if standard treatments have not worked.
This early-phase trial tests GC101 TIL, a treatment made from your own melanoma tumor cells, for advanced melanoma. It may help the immune system better fight the cancer after standard treatments have already stopped working or if none are available.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.